CACuneyd Anil

Cuneyd Anil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cuneyd Anil has a total of 185 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical characteristics of Graves’ disease following COVID-19 infection or vaccination: a multicenter case-control study

    by Asena Gökçay Canpolat, Kemal Ağbaht, Ati̇lLa Hali̇l Elhan, Mustafa Cesur, Zi̇yNet Alphan Uç, Seçki̇n Akçay, Hülya Iliksu Gözü, Mehmet Aşik, Hayri̇ Bostan, Beki̇r Ucan, et al.

    Background/aim: To describe Graves’ Disease (GD) associated with COVID-19 infection (COVID) or its vaccines (VAC) and to compare the clinical presentations, laboratory parameters, and short-term clinical course of the disease among different etiology groups (COVID, VAC, and GD control). Materials and methods: Included in this multicenter matched case–control, retrospective cohort study were 239 patients with newly diagnosed (n = 196) or recurrent GD (n = 43) associated with COVID (n = 79) or VAC (n = 160). Each case was matched (1:1) with a control who had been diagnosed with GD prior to COVID. Results: The median age of the entire group was 42 years (female:male = 137:102). Both the COVID (4.6-fold) and VAC (4.1-fold) groups demonstrated higher TSH receptor antibody (TRAb) titers (p < 0.001) compared with the control group (3.5-fold), as well as a higher proportion of recurrent cases. At baseline, the COVID group had higher free triiodothyronine (fT3) levels than the other groups. Graves orbitopathy (GO) was observed in 60 patients (12.6%), with a higher frequency in classical GD (18.4%). At baseline, the variables associated with thyrotoxicosis severity (defined as fT3 levels) were younger age, higher thyroid gland volume (TGV), and etiology, with the COVID and, to a lesser extent, VAC groups presenting with higher fT3 levels. The variables associated with GO were higher TGV, TRAb titers, and smoking, while no association with etiology was identified. Conclusion: The clinical course was similar in all groups other than in some laboratory findings. Although the frequency of GO associated with COVID and VAC was lower, the proportion of cases with a Clinical Activity Score of ≥3 was higher compared to GD. This pattern suggests a potentially stronger immunologic trigger in these cases.


  • Open Access

    Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study

    by Adnan Batman, Dilek Yazıcı, Oğuz Dikbaş, Kemal Ağbaht, Emre Sedar Saygılı, İbRahim Demirci, Nurbanu Bursa, Görkem Ayas, Cüneyd Anıl, Mustafa Cesur, et al.

    Context: The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism. Methods: This nationwide, multicenter, retrospective cohort study included 53 endocrinology centers in Turkey. The study participants were divided into either COVID-19–related SAT (Cov-SAT), SARS-CoV-2 vaccine–related SAT (Vac-SAT), or control SAT (Cont-SAT) groups. Results: Of the 811 patients, 258 (31.8%) were included in the Vac-SAT group, 98 (12.1%) in the Cov-SAT group, and 455 (56.1%) in the Cont-SAT group. No difference was found between the groups with regard to laboratory and imaging findings. SAT etiology was not an independent predictor of recurrence or hypothyroidism. In the entire cohort, steroid therapy requirement and younger age were statistically significant predictors for SAT recurrence. C-reactive protein measured during SAT onset, female sex, absence of antithyroid peroxidase (TPO) positivity, and absence of steroid therapy were statistically significant predictors of incident (early) hypothyroidism, irrespective of SAT etiology. On the other hand, probable predictors of established hypothyroidism differed from that of incident hypothyroidism. Conclusion: Since there is no difference in terms of follow-up parameters and outcomes, COVID-19– and SARS-CoV-2 vaccine–related SAT can be treated and followed up like classic SATs. Recurrence was determined by younger age and steroid therapy requirement. Steroid therapy independently predicts incident hypothyroidism that may sometimes be transient in overall SAT and is also associated with a lower risk of established hypothyroidism.


  • Open Access

    Sympathetic skin responses and electromyographic reaction times in chronic autoimmune thyroiditis: An overlooked electrodiagnostic study

    by Oya Ümit Yemişci, Selin Özen, Tubanur Öztürk Şişman, Cüneyd Anıl, Sacide Nur Saraçgil Coşar

    Objectives: This study aims to evaluate peripheral nerve functions, sympathetic skin responses (SSRs), and electromyographic (EMG) reaction times in hypothyroid patients and to compare them to healthy individuals. Patients and methods: Between January 2007 and September 2007, a total of 54 patients with Hashimoto’s thyroiditis including 35 euthyroid (3 males, 32 females; mean age: 45.2±10.2 years; range, 35 to 60 years) and 19 with subclinical hypothyroidism (2 males, 17 females; mean age: 43.2±12.6 years; range, 40 to 65 years) were included in the study. The control group consisted of 35 healthy individuals (5 males, 30 females; mean age: 39.1±9.3 years; range, 29 to 52 years). Nerve conduction studies (NCSs), SSRs of the hand and foot obtained by stimulation of the contralateral median nerve, and EMG reaction times of the extensor indicis proprius muscle were performed in all subjects. Results: There was no significant difference in peripheral NCSs and SSRs between patients and the control group. However, reaction times were longer in the AIT patients compared to the healthy individuals suggesting alterations in cognitive function related to the primary disease process in AIT. Conclusion: Electrodiagnosis of autonomic nervous system involvement and cognitive impairment can be challenging in AIT. However, EMG reaction times and SSRs are practical and useful tools that are often overlooked. On the other hand, SSRs may be combined with more quantitative tests, such as sudomotor axon reflex testing, to allow us to better determine the extent of involvement of the autonomic nervous system in AIT.


  • Open Access

    The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma

    by Nazlı GÜLSOY KIRNAP, Özlem Turhan İyİdİr, Yusuf Bozkuş, Şerife Mehlika Işildak, Cüneyd Anil, Sevde Nur Firat, Canan Demi̇r, Aslı NAR, Neslihan Başçil Tütüncü

    Background/aim; Overt thyroidism is known to cause neuropsychiatric disorders but studies on subclinical hyperthyroidism (SCH) are limited. Subclinical hyperthyroidism induction by administering L-Thyroxine (LT4) is the standard treatment method in differentiated thyroid carcinoma (DTC) follow-up. Our aim was to investigate whether anxiety, depression and quality of life are affected in DTC patients followed-up with exogenous SCH. The patients were divided into exogenous SCH by LT4 -DTC (n= 127), euthyroid-DTC (n= 66) and exogenous euthyroid- benign thyroid nodüle (BTN) who underwent thyroidectomy for benign thyroid pathology (n= 85) groups. The rate of moderate/severe anxiety was significantly higher in SCH-DTC than euthyroid-BTN group (27.5%, n= 35 vs. 9.4%, n= 8) (p= 0.001). TSH levels and Beck anxiety inventory (BAI) scores were significantly negatively correlated (p= 0.009 r= -0.16). Free T4 and BAI were significantly positively correlated (p= 0.04 r= 0.4). The groups were similar in terms of depression severity (p= 0.15). Subclinical hyperthyroid- DTC group scored significantly lower than euthyroid-BTN group in all scales of SF-36 quality of life survey. LT4-induced SCH, which is a part of traditional DTC treatment, can exacerbate the anxiety symptoms in patients and disrupt their quality of life, depending on the level of fT4.


  • Open Access

    Do Statins Affect Thyroid Volume and Nodule Size in Patients with Hyperlipidemia in a Region with Mild-to-Moderate Iodine Deficiency? A Prospective Study

    by Canan Demir, Cuneyd Anil, Yusuf Bozkus, Umut Mousa, Altug Kut, Asli Nar, Neslihan B. Tutuncu

    Objective: The objective of this study was to assess the antiproliferative pleiotropic effects of statins on thyroid function, volume, and nodularity. Subjects and Methods: One hundred and six hyperlipidemic patients were included in this prospective study. The 69 patients in the statin groups received atorvastatin (16 received 10 mg and 18 received 20 mg) or rosuvastatin (20 received 10 mg and 15 received 20 mg). The 37 patients in the control group, assessed as not requiring drugs, made only lifestyle changes. Upon admission and after 6 months, all patients were evaluated by ultrasonography as well as for lipid variables (total cholesterol, high- and low-density lipoprotein cholesterol, and triglycerides) and thyroid function and structure. Results: After 6 months, no differences in thyroid function, thyroid volume, the number of thyroid nodules, or nodule size were observed in the statin and control groups. In a subgroup analysis, total thyroid volume had decreased more in patients receiving 20 mg of rosuvastatin than that in the control group (p < 0.05). Maximum nodule size had decreased more in those receiving 10 mg of rosuvastatin (p < 0.05). Conclusions: Our results suggest an association between rosuvastatin treatment and smaller thyroid volume and maximum nodule diameter; this could be attributable to the antiproliferative effects of statin therapy on the thyroid.


  • Open Access

    Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study

    by Cuneyd Anil, Altug Kut, Berna Atesagaoglu, Asli Nar, Neslihan Bascil Tutuncu, Alptekin Gursoy

    Objective: The aim of this study was to investigate the effects of metformin on thyroid volume and nodule size. Subjects and Methods: Prospective data were gathered on 100 newly diagnosed subjects with insulin resistance (68 female, 32 male) between August 2008 and May 2010. Each subject followed a standard diet and exercise program, and received 1,700 mg/day of metformin therapy for 6 months. The height, weight, waist circumference (WC) and thyroid hormone levels of each subject were measured. Additionally, the dimensions of the thyroid lobes and maximum diameter of each thyroid nodule were determined by ultrasonography. BMI and thyroid volumes were also calculated. Insulin resistance was estimated by homeostasis model assessment. All these parameters were measured at the beginning and at the end of the treatment period. Results: BMI and WC decreased significantly after metformin therapy (34.5 ± 5.1 vs. 32.7 ± 4.8, p < 0.0001, and 106.3 ± 11.8 vs. 101.8 ± 19.0 cm, p = 0.008, respectively). Insulin resistance also decreased after metformin therapy (4.5 ± 1.9 vs. 2.9 ± 1.7, p < 0.0001). The mean thyroid volume (22.5 ± 11.2 vs. 20.3 ± 10.4 ml, p < 0.0001) and mean thyroid nodule size (12.9 ± 7.6 vs. 11.7 ± 7.2 mm, p < 0.0001) also decreased after treatment. Conclusion: In subjects with insulin resistance, metformin therapy significantly decreased thyroid volume and nodule size.


  • Prevalence of orthorexia in diabetic patients

    by Cuneyd Anil, Gozde Aritici, Hacer Ari, Neslihan Bascil Tutuncu

    Introduction: Orthorexia (nervosa) is an eating disorder, characterised by an obsession with avoiding foods perceived to be unhealthy. Though it has not been recognised as a pathological entity in Diagnostic and Statistical Manual of Mental Disorders – IV yet, interest in the condition has increased recently. This study aimed to determine the prevalence and risk factors of orthorexia in a group of diabetic patients. Methods and design: 134 (63 female) diabetic patients who admitted to the outpatient clinic of our department were enrolled. Demographic information, educational status, diabetic history, care, and treatment, height, and weight of all cases were recorded. Ortho-15 Questionnaire was applied to all participants. Each patient can score minimum 15, maximum 60 points from this test. Those scoring 40 points and less are accepted to be orthorectic. Results: The mean age of the group was 59.9±11.7 years. The Ortho-15 test revealed that the minimum score was 25, and the maximum 46 points. No relation was determined between educational status, BMI and presence of orthorexia. 15.5% of males and 11.1% of females were found to be orthorectic (P>0.05). The mean duration of diabetes of the whole group was 10.1±8.8 years and there was no relation between duration of diabetes and presence of orthorexia. Conclusion: This study revealed that orthorexia was not frequent in this group of patients. Performing the test on larger groups making comparisons, may introduce different results.


  • Ultrasonographic and cytopathological characteristics of thyroid nodules in Graves' disease

    by Cuneyd Anil, Nazli Gulsoy Kirnap, Ozlem Turhan Iyidir, Sevde Nur Firat, Neslihan Bascil Tutuncu

    Introduction: The risk of malignancy has often been reported to be more frequent in Graves’ disease (GD) than non-autoimmune thyroid nodules. However, frequency of thyroid nodules, diagnostic yield of fine-needle aspiration (FNA), and their potential for bearing malignancy in GD are still debatable issues. We aimed to determine the prevalence, ultrasonographic and cytological features, and the rate of malignancy outcome of thyroid nodules in a group of patients with GD. Methods: This was a single center retrospective study. All patients with GD followed up in the Outpatient Clinic of Department of Endocrinology between 2008 and 2013 were included. Thyroid hormone, thyroid autoantibody, TSH receptor antibody (TRAb) levels of all cases during diagnosis were recorded. Basic ultrasonographic data, cytological results of every nodule which underwent fna, and the histopathological data were also recorded. Results: 175 cases (132 females) with mean±S.D. age 45.9±15.8 were included. 58.8% of the whole group were TRAb positive. 81.1% (n=142) of the patients were treated with anti-thyroid drugs. 14.3% (n=25) were finally treated with radioactive iodine with a median (min–max) dose of 12 mCi (5–20). 40% (n=70) of the cases had totally 134 thyroid nodules. The median (min–max) value of maximum diameter of thyroid nodules was 10.0 (3–54) mm. 14.8% of the nodules owned microcalcifications. 23% (n=28) nodules underwent FNA. Cytopathology revealed that 24 were benign, two were indeterminate, and the last two were non-diagnostic, both of which were also eventually benign in repeat aspirations. The indeterminate nodules went to surgery, which turned out to be benign. Eight additional patients underwent surgery for ablative purposes; only one turned out to be malignant, which was incidental. Conclusion: Nodular goitre is prevalent in GD. Diagnostic yield of fna may not be so low; malignancy rates do not seem to be high in this group of patients.

  • Indications and outcomes of repeated thyroid fine-needle aspirations: a retrospective evaluation from a tertiary centre

    by Sevde Nur Firat, Ozlem Turhan Iyidir, Mehlika Isildak, Cuneyd Anil, Nazli Kirnap Gursoy, Asli Nar, Neslihan Bascil Tutuncu

    Introduction: Fine needle aspiration (FNA) is the first-line diagnostic test for evaluating thyroid nodules. This test can effectively distinguish between neoplastic and non neoplastic nodules. The Bethesda System suggest that thyroid nodules with non diagnostic (ND), atypia/follicular lesions of undetermined significance (A/FLUS) aspiration should undergo repeat sampling. We aimed to investigate the clinical validity of repeated FNA in the management of patients with thyroid nodules in our institution. Methods/design: In this study we evaluated 668 nodules of 529 patients who undergone repeated sampling in Başkent University Hospital between 2000 and 2014. Results: The majority of patients were female (n=421, %79.6). The mean age of patients was 60.1±14.5 years. First evaluation revealed that 467 (89.9%) of nodules were benign, 180 (26.9%) were non diagnostic and 21 (3.1%) were A/FLUS). Enlargement of the nodule (%27.9) was the most common indication for a repeated sampling followed by non-diagnostic cytology (%26.9). Re-aspiration altered the initial diagnosis in 84.4% and 66.7% of the non-diagnostic and (A/FLUS) patients but only in 10.7% of patients with a benign cytology the initial diagnosis was changed. We evaluated the outcome of patients whose initial and repeated cytological diagnosis are non diagnostic and A/FLUS (Table 1). Outcome data was obtained 23 (65.7%) of these patients. Table 1 Outcome data of patients with initial and repeated diagnosis of non diagnostic and A/FLUS. FNA1–FNA2 Surgery Repeated biopsy ND-ND (n=28) Nodular hyperplasia-6 Papillary thyroid ca-2 Benign-7 ND-1 A/FLUS (n=7) Nodular hyperplasia-5 Benign-2 FNA, fine needle aspiration; ND, non-diagnostic; A/FLUS, atypia/follicular lesions of undetermined significance. Conclusion: Repeat FNA is useful in cases whose initial diagnosis is non diagnostic or A/FLUS, but repeated aspiration for patients with an initial benign examination appears to not increase the expected likelihood of a malignant cytology.

  • Knowledge, attitudes and behaviors of physicians towards thyroid disorders and iodine requirements in pregnancy

    by A. Kut, H. Kalli, C. Anil, U. Mousa, A. Gursoy

    Thyroid disorders including iodine deficiency during pregnancy are important health problems worldwide. However, considering real life, assessment of knowledge, attitudes, and practice of physicians is lacking. We aim to evaluate knowledge, attitudes and behaviors of physicians towards thyroid disorders and requirements of iodine during pregnancy on a nationwide basis. Clinicians from different medical disciplines most likely to encounter pregnant women in daily practice (i.e., obstetricians, endocrinologists, and family physicians) were included. Family physicians were selected from primary care centers; endocrinologists and gynecologists were selected from state hospitals. Randomly selected 322 physicians from seven geographical regions of Turkey were included. Subjects filled a questionnaire which consisted of three sections about knowledge, attitudes and behaviors towards thyroid disorders and iodine requirements during pregnancy. Physicians had insufficient and/or erroneous knowledge about thyroid disorders during pregnancy. 73.1 % of endocrinologists, 32.7 % of family physicians, and 17.8 % of obstetricians knew the correct level of TSH during pregnancy (p p Physicians who encounter pregnant women in Turkey do not have sufficient information about management of thyroid disorders and providing iodine support during pregnancy and lactation.